Tumor-supporting function of CD204+ TAMs was demonstrated for lung cancer and glioma, however anti-tumor function was shown for breast cancer, ovarian cancer and pancreatic cancer (21, 24, 25, 27, 74–76). Here, MSR1 is linked to breast carcinoma.